Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine

By Trivello R.   Chiaramonte M.   Ngatchu T.   Baldo V.   Majori S.   Moschen M.E.   Simoncello I.   Renzulli G.   Naccarato R.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 139-141

Elsevier

Access to resources Recommend Favorite

Subtype specificity of anti-HBs antibodies produced by human B-cell lines isolated from normal individuals vaccinated with recombinant hepatitis B vaccine

By Shokrgozar M.A.   Shokri F.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2215-2220

Elsevier

Access to resources Recommend Favorite

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

By Van Herck K.   Van Damme P.   Thoelen S.   Meheus A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1933-1935

Elsevier

Access to resources Recommend Favorite

Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years

By Da Villa G.   Peluso F.   Picciotto L.   Bencivenga M.   Elia S.   Pelliccia M.G.  

Vaccine, Vol. 14, Iss. 16, 1996-11 ,pp. : 1503-1505

Elsevier

Access to resources Recommend Favorite

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load

By Rey D.   Krantz V.   Partisani M.   Schmitt M.-P.   Meyer P.   Libbrecht E.   Wendling M.-J.   Vetter D.   Nicolle M.   Kempf-Durepaire G.   Lang J.-M.  

Vaccine, Vol. 18, Iss. 13, 2000-01 ,pp. : 1161-1165

Elsevier

Access to resources Recommend Favorite